[HTML][HTML] Prospective assessment of vincristine-induced peripheral neuropathy in paediatric acute lymphoblastic leukemia
Objective Vincristine is a mainstay treatment for paediatric cancers, particularly acute
lymphoblastic leukemia (ALL), with common toxicity including vincristine-induced peripheral …
lymphoblastic leukemia (ALL), with common toxicity including vincristine-induced peripheral …
Vincristine and Peripheral Neuropathy in Acute Lymphoblastic Leukemia Children
T Thongmak, N Yuthasompop - Journal of Health Science and …, 2024 - 150.95.98.117
Objective: Peripheral neuropathy is a common neurological side effect in acute
lymphoblastic leukemia (ALL) pediatric patients, receiving vincristine treatment. This study …
lymphoblastic leukemia (ALL) pediatric patients, receiving vincristine treatment. This study …
Identifying Risk Factors, Phenotypes and Outcome Measures for Chemotherapy-Induced Peripheral Neuropathy with a Focus on the Treatment of Haematological …
T Li - 2023 - ses.library.usyd.edu.au
This thesis evaluated the various approaches to assessing chemotherapy-induced
peripheral neuropathy (CIPN) to identify the optimal outcome measure and further provided …
peripheral neuropathy (CIPN) to identify the optimal outcome measure and further provided …